Immuron (IMRN) News Today → Does this make you sick? (From Allegiance Gold) (Ad) Free IMRN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsHeadlinesShort InterestSocial MediaStock AnalysisCompetitorsHeadlinesShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 7, 2024 | globenewswire.comImmuron Limited to Present at the Emerging Growth ConferenceMay 3, 2024 | globenewswire.comImmuron Director ResignationApril 15, 2024 | finance.yahoo.comImmuron Limited (IMRN) Interactive Stock Chart - Yahoo FinanceApril 15, 2024 | globenewswire.comImmuron to host Live Virtual EventApril 10, 2024 | finanznachrichten.deImmuron Limited: Immuron Travelan sales continued strong growthApril 10, 2024 | msn.comImmuron gains after Travelan sales updateApril 10, 2024 | globenewswire.comImmuron Travelan® sales continued strong growthMarch 27, 2024 | ca.finance.yahoo.comImmuron Limited (IMRN) Latest Stock News & Headlines - Yahoo FinanceMarch 22, 2024 | investing.comImmuron Ltd ADR (IMRN)March 7, 2024 | msn.comImmuron surges after mid-stage data for antidiarrheal medMarch 7, 2024 | globenewswire.comImmuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USMarch 7, 2024 | msn.comASX Health Stocks: Immuron leaps 80pc after announcing that Travelan trials will move to Phase 3March 5, 2024 | marketbeat.comTrading was temporarily halted for "IMRN" at 07:03 PM with a stated reason of "News pending."February 22, 2024 | benzinga.comImmuron Stock (NASDAQ:IMRN) Dividends: History, Yield and DatesFebruary 21, 2024 | globenewswire.comImmuron Presentation Australian Biologics Festival 2024February 13, 2024 | finanznachrichten.deImmuron Limited: Immuron achieves record Travelan salesFebruary 13, 2024 | finance.yahoo.comImmuron achieves record Travelan® salesJanuary 16, 2024 | finanznachrichten.deImmuron Limited: Immuron achieves record half yearly Travelan salesJanuary 16, 2024 | finance.yahoo.comImmuron achieves record half yearly Travelan® salesJanuary 15, 2024 | msn.comASX Health Stocks: Immuron chalks up record half for travelers’ diarrhoea medicine, TravelanJanuary 15, 2024 | au.investing.comImmuron chalks up stellar half-year Travelan sales as travel returns to pre-pandemic levelsDecember 22, 2023 | finance.yahoo.comImmuron Clinical Trials UpdateDecember 4, 2023 | proactiveinvestors.comImmuron enrols first patients in Campylobacter Challenge clinical studyDecember 4, 2023 | markets.businessinsider.comImmuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNovember 28, 2023 | finance.yahoo.comImmuron CEO, Steven Lydeamore Investor Webinar PresentationNovember 13, 2023 | finance.yahoo.comImmuron CEO Steven Lydeamore Investor Webinar PresentationNovember 1, 2023 | au.investing.comImmuron receives bull case valuation of A$0.35 from Pitt Street ResearchOctober 31, 2023 | proactiveinvestors.comImmuron receives bull case valuation of A$0.35 from Pitt Street...October 30, 2023 | markets.businessinsider.comImmuron CEO Steven Lydeamore presented at AusBioInvestOctober 18, 2023 | au.investing.comImmuron signs up second cohort for clinical trial assessing Travelan® in the prevention of travellers' diarrhoeaOctober 18, 2023 | benzinga.comImmuron Announces Travelan® Clinical Study Cohort 2 commencesOctober 11, 2023 | finance.yahoo.comImmuron achieves record quarterly Travelan® salesOctober 4, 2023 | au.investing.comImmuron to present at LD Micro Main EventSeptember 18, 2023 | finance.yahoo.comImmuron Limited Announces Participation in the LD Micro Main Event XVISeptember 14, 2023 | proactiveinvestors.com.auImmuron hails record monthly sales of TravelanSeptember 13, 2023 | msn.comImmuron achieves record monthly Travelan salesSeptember 13, 2023 | finance.yahoo.comImmuron achieves record monthly Travelan® salesSeptember 13, 2023 | proactiveinvestors.comImmuron posts record A$1.18 million monthly sales for Travelan; shares jumpSeptember 11, 2023 | finance.yahoo.comImmuron CEO, Steven Lydeamore to present at H.C. WainwrightAugust 14, 2023 | finance.yahoo.comImmuron to present at the Military Health System Research SymposiumAugust 14, 2023 | proactiveinvestors.comImmuron presenting at US military health symposiumJuly 27, 2023 | finance.yahoo.comImmuron welcomes launch of Travelan on Amazon USJuly 25, 2023 | finanznachrichten.deImmuron Limited: Immuron Announces First Patients Enrolled in Travelan Clinical StudyJuly 25, 2023 | finance.yahoo.comImmuron Announces First Patients Enrolled in Travelan® Clinical StudyJuly 25, 2023 | proactiveinvestors.comImmuron enrols first patients in Travelan® clinical studyJuly 24, 2023 | benzinga.comImmuron CEO, Steven Lydeamore to present at BiosharesJuly 19, 2023 | finance.yahoo.comImmuron Ltd. Describes How their Gastrointestinal and Digestive Health Immune Supplements Work + FY23 Sales Announcement in New CEO Video Interview on Planet MicroCapJuly 12, 2023 | proactiveinvestors.com.auImmuron’s strategic investee launches gut health supplement Juvia in AustraliaJuly 11, 2023 | finance.yahoo.comImmuron Business Update - Ateria Health launches Juvia™ in AustraliaJuly 5, 2023 | finance.yahoo.comImmuron FY23 Sales increase 136% on FY22 Sales Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)Elon Musk just Triggered a BOOM in These Stocks Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Click here to sign up for our free report & newsletter IMRN Media Mentions By Week IMRN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMRN News Sentiment▼0.000.43▲Average Medical News Sentiment IMRN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMRN Articles This Week▼01▲IMRN Articles Average Week Get Immuron News Delivered to You Automatically Sign up to receive the latest news and ratings for IMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PPBT News Today KPRX News Today RDHL News Today ERNA News Today IMNN News Today PIRS News Today HUGE News Today EDSA News Today AKTX News Today MNPR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMRN) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.